Altan is committed to building strong partnerships with companies that share our vision of improving lives through high quality, affordable health care.
We have a broad portfolio of quality injectable drugs and a good presence in many regions around the globe; however, many opportunities remain. Our goal is to actively expand our global footprint and product portfolio by:
- Out-licensing products to select partners with access to attractive markets where we don’t currently have a significant presence;
- In-licensing or acquiring specialty pharmaceutical products to broaden our line; and
- Acquiring strategic assets that enhance our development, manufacturing and/or commercial capabilities globally.
If you have licensing and/or acquisition opportunities that you believe may be of interest to Altan, please submit inquires on a non-confidential basis to: